Nevakar Injectables Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 53

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $12M

  • Investors
  • 1

Nevakar Injectables General Information

Description

Operator of a specialty injectable pharmaceutical company in Bridgewater, New Jersey. The company is focused on developing innovative products in the injectable and ophthalmic space with the aim to develop enhanced products, helping address unmet clinical and commercial needs of currently FDA-approved molecules, through intensive R&D and clinical efforts.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 1019 US Highway, NJ Center of Excellence
  • Suite 202-206, Building K
  • Bridgewater, NJ 08807
  • United States
+1 (908) 000-0000

Nevakar Injectables Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nevakar Injectables Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Feb-2022 $12M 00000 Completed Generating Revenue
4. Debt - PPP 09-Apr-2020 00.000 00000 Completed Generating Revenue
3. Debt - General 18-Jun-2019 0000 00000 Completed Generating Revenue
2. Debt - General 29-Nov-2018 $20M $75M Completed Generating Revenue
1. Angel (individual) 27-Jul-2016 $55M $55M Completed Generating Revenue
To view Nevakar Injectables’s complete valuation and funding history, request access »

Nevakar Injectables Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a specialty injectable pharmaceutical company in Bridgewater, New Jersey. The company is focused on developi
Pharmaceuticals
Bridgewater, NJ
53 As of 2022
00000
0000000000 0 00000

000 00

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt m
000000000000000
Ramapo, NY
0000 As of 0000
000.00
0.000 0000-00-00
000000&0 000.00

00000

llum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Mumbai, India
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nevakar Injectables Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Par Pharmaceutical Companies Formerly PE-Backed Ramapo, NY 0000 000.00 000000&0 000.00
00000 Corporation Mumbai, India 00000 00000000
00000 Corporation Lake Forest, IL 0000 0000000000.
00000000 000000000 Corporation Mumbai, India 00000 00000 000000000 00000
0000000 0000000 Corporation Trevose, PA 000 000000000
You’re viewing 5 of 21 competitors. Get the full list »

Nevakar Injectables Patents

Nevakar Injectables Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10869845-B1 Ephedrine compositions and methods Active 22-Jan-2020 0000000000
US-20210228506-A1 Ephedrine compositions and methods Pending 22-Jan-2020 0000000000
US-20220296515-A1 Vancomycin liposome compositions and methods Pending 28-May-2019 000000000
EP-3975995-A1 Vancomycin liposome compositions and methods Pending 28-May-2019 0000000000
US-10722454-B1 Succinylcholine prefilled syringe, compositions and methods Active 13-Aug-2018 A61K31/225
To view Nevakar Injectables’s complete patent history, request access »

Nevakar Injectables Executive Team (9)

Name Title Board Seat Contact Info
Sriram Ramanathan Chief Executive Officer
Marshall Woodworth Chief Financial Officer
Jon Cammack Ph.D Chief Quality & Compliance Officer
Kumaresh Soppimath Ph.D Chief Scientific Officer
Raul Trillo Chief Commercial Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Nevakar Injectables Board Members (5)

Name Representing Role Since
George Zorich Self Board Member 000 0000
Joseph Mahady Nevakar Injectables Board Member 000 0000
Navneet Puri Ph.D Nevakar Injectables Founder & Chairman of the Board 000 0000
Ram Potti Self Board Member 000 0000
Robert Spiegel MD Self Board Member 000 0000
To view Nevakar Injectables’s complete board members history, request access »

Nevakar Injectables Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nevakar Injectables Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Oxford Finance Lender/Debt Provider 000 0000 000000 0
To view Nevakar Injectables’s complete investors history, request access »